RadioGel® is not FDA-approved for commercial use in the United States.

RadioGelUSA
Home
The Science of RadioGel®
Subscribe
PRnT™
Research Papers
IDE Submission
Press Releases
RadioGel® Cancer Blog
Meet The Team
Contact Us
Vivos Inc.
IsoPet®
RadioGelUSA
Home
The Science of RadioGel®
Subscribe
PRnT™
Research Papers
IDE Submission
Press Releases
RadioGel® Cancer Blog
Meet The Team
Contact Us
Vivos Inc.
IsoPet®
More
  • Home
  • The Science of RadioGel®
  • Subscribe
  • PRnT™
  • Research Papers
  • IDE Submission
  • Press Releases
  • RadioGel® Cancer Blog
  • Meet The Team
  • Contact Us
  • Vivos Inc.
  • IsoPet®
  • Sign In
  • Create Account
  • My Account

  • Signed in as:

  • filler@godaddy.com

  • My Account

  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • The Science of RadioGel®
  • Subscribe
  • PRnT™
  • Research Papers
  • IDE Submission
  • Press Releases
  • RadioGel® Cancer Blog
  • Meet The Team
  • Contact Us
  • Vivos Inc.
  • IsoPet®

Account

  • My Account

  • Sign out

  • Sign In
  • My Account

PRESS RELEASES

 Press Releases - Vivos Inc.

GlobeNewsWire has a list of all press releases for up-to-date information on our revolutionary cancer treatment - Precision Radionuclide Therapy™ (PRnT™) for our products - RadioGel and IsoPet 

Read Press Releases

Copyright © 2025 RadioGel™ - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept